/PRNewswire/ The sudden drop in use of the COVID treatment remdesivir was the main cause of a 5.2% dip in drug spending for hospitals last year compared to.
Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP s (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021. Shifts in care related to the pandemic will continue to be a significant driver of drug expenditures in 2021, along with uptake in the use of biosimilars, a large pipeline of new cancer drugs, and increased approvals of specialty medications.
Prescription drug spending in 2020 grew at a moderate rate of 4.9% to $535.3 billion. Increased utilization drove the growth, which accounted for 2.9% of the total increase. Spending on new drugs accounted for 1.8% of the increase, and price changes accounted for 0.3%.
Covid to drive US prescription drug spending in 2021: Study prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
The COVID-19 pandemic heavily influenced spending on prescription drugs in the U.S. in 2020, according to the ASHP s (American Society of Health-System Pharmacists) National Trends in Prescription Drug Expenditures and Projections for 2021. Shifts in care related to the pandemic will continue to be a significant driver of drug expenditures in 2021, along with uptake in the use of biosimilars, a large pipeline of new cancer drugs, and increased approvals of specialty medications.